CLINICAL GENOMICS: YOUR PARTNER IN EARLIER DETECTION.
InSure ONE is an easy, one-day fecal immunochemical test that uses a sample of water collected with a brush to detect lower GI bleeding.
DETECTING RESIDUAL DISEASE
COLVERA is a clinically validated circulating tumor DNA (ctDNA) blood test designed to detect minimal residual disease after surgical resection in CRC patients.
Clinical Genomics harnesses breakthrough science to create innovative and accessible ways to detect disease and enhance lives.
Clinical Genomics is committed to developing and delivering solutions that provide physicians and their patients with information to help guide earlier and better treatment decisions in cancer care management.
Copyright © 2018 Clinical Genomics Technologies Pty Ltd. All Rights Reserved.